Veeco Instruments Inc. (VECO) - Q1 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. Veeco Instruments Inc. is a manufacturer of semiconductor and thin film process equipment, operating as a single reportable segment. The company is currently in the process of a pending merger with Axcelis Technologies, Inc., approved by stockholders in February 2026, with closing expected in the second half of 2026 subject to regulatory approvals.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $158.3 million | $167.3 million |
| Gross Profit | $55.8 million | $68.5 million |
| Gross Margin | 35.3% | 40.9% |
| Operating Income (Loss) | $(2.7) million | $14.1 million |
| Net Income (Loss) | $(0.3) million | $11.9 million |
| Diluted EPS | $(0.01) | $0.20 |
| Cash and Cash Equivalents | $179.5 million | $175.1 million |
| Short-term Investments | $203.8 million | $226.8 million |
| Long-term Debt | $226.3 million | $226.0 million |
| Operating Cash Flow | $7.9 million | $20.0 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 5% year-over-year, primarily driven by a 12% drop in Semiconductor revenue and a 9% decline in Scientific & Other markets.
- Geographic Shift: Sales in China plummeted 72% to $20.0 million, significantly offset by a 51% increase in "Rest of APAC" (excluding China) to $90.4 million and a 34% increase in U.S. sales.
- Margin Compression: Gross margin contracted to 35.3% from 40.9% due to unfavorable product mix, higher logistics costs, and lower sales volume.
- Operating Loss: The company reported an operating loss of $2.7 million compared to an operating income of $14.1 million in the prior year. This was driven by lower gross profit and $2.0 million in merger-related costs.
- Profitability: Net income turned negative at a loss of $0.3 million, compared to $11.9 million in Q1 2025.
Guidance, Outlook, and Risks
- Merger Status: The merger with Axcelis is expected to close in H2 2026 pending final regulatory approval from China's State Administration for Market Regulation. Termination fees of $108.7 million (Axcelis) and $77.5 million (Veeco) apply under specific conditions.
- Market Outlook: Management anticipates growth in the Semiconductor market driven by AI and high-performance computing. Significant order activity ($250 million+) was noted in the Compound Semiconductor market for InP lasers, with deliveries starting in 2026 and accelerating in 2027.
- Tariff Uncertainty: Following a U.S. Supreme Court decision invalidating certain tariffs, the company is evaluating potential refunds but has not recorded adjustments due to uncertainty regarding amounts and timing.
- Key Risks: Risks include the pendency of the merger, global trade disputes, export controls, reliance on a concentrated customer base, and the cyclicality of the semiconductor industry.
Investor Verification Checklist
- Verify the status of the pending regulatory approval from China for the Axcelis merger.
- Monitor the trajectory of China sales, which dropped 72% YoY, and assess the sustainability of the offsetting growth in Rest of APAC.
- Review the impact of the $2.0 million in merger costs on future quarters and the potential for integration expenses post-closing.
- Assess the realization of the $250 million+ in new orders for Compound Semiconductor tools and their expected revenue recognition timeline.
- Track the company's progress in filing claims for tariff refunds following the recent Supreme Court ruling.